V. Barak

911 total citations
28 papers, 774 citations indexed

About

V. Barak is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, V. Barak has authored 28 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in V. Barak's work include Glycosylation and Glycoproteins Research (3 papers), Immune Cell Function and Interaction (3 papers) and Immune Response and Inflammation (3 papers). V. Barak is often cited by papers focused on Glycosylation and Glycoproteins Research (3 papers), Immune Cell Function and Interaction (3 papers) and Immune Response and Inflammation (3 papers). V. Barak collaborates with scholars based in Israel, United States and France. V. Barak's co-authors include Benjamin Nisman, Yoram Abramov, Joseph G. Schenker, I. Kalickman, Aya Abrahamov, S Yatziv, Ari Zimran, David Hasdai, Mickey Scheinowitz and M. Eldar and has published in prestigious journals such as Blood, American Journal of Obstetrics and Gynecology and Medicine & Science in Sports & Exercise.

In The Last Decade

V. Barak

28 papers receiving 738 citations

Peers

Countries citing papers authored by V. Barak

Since Specialization

Citations

This map shows the geographic impact of V. Barak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Barak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Barak more than expected).

Fields of papers citing papers by V. Barak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Barak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Barak. The network helps show where V. Barak may publish in the future.

Co-authorship network of co-authors of V. Barak

This figure shows the co-authorship network connecting the top 25 collaborators of V. Barak. A scholar is included among the top collaborators of V. Barak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Barak. V. Barak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TUMOR NECROSIS FACTOR AND INTERLEUKIN-6 LEVELS IN HYPERTENSIVE PATIENTS WITH AND WITHOUT LEFT VENTRICULAR HYPERTROPHY 2004 ·Journal of Hypertension ·David Leibowitz, David Planer, V. Barak, (unknown), (unknown)	1
2	Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome 2001 ·American Journal of Obstetrics and Gynecology ·Yoram Abramov, S.O. Anteby, Sozos J. Fasouliotis, V. Barak	50
3	Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. 2000 ·PubMed ·Benjamin Nisman, G Amir, Joel Lafair, Norman Heching, Olga Lyass, Tamar Peretz, V. Barak	40
4	Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome? 1999 ·PubMed ·Eli Geva, Ami Amit, Joseph B. Lessing, Liat Lerner‐Geva, (unknown), Israel Yovel, (unknown), V. Barak	21
5	Cytokines in Gaucher's disease. 1999 ·PubMed ·V. Barak, (unknown), Benjamin Nisman, I. Kalickman, Aya Abrahamov, Ari Zimran, S Yatziv	154
6	Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type response. 1999 ·PubMed ·Yaron Tomer, V. Barak, Boris Gilburd, Yehuda Shoenfeld	12
7	Cytokeratin Markers in Malignant Pleural Mesothelioma 1998 ·Cancer Detection and Prevention ·Benjamin Nisman, V. Barak, Norman Heching, Michael Krämer, Constantin Reinus, Joel Lafair	9
8	Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome 1997 ·Fertility and Sterility ·Yoram Abramov, V. Barak, Benjamin Nisman, Joseph G. Schenker	150
9	Induction of tumor necrosis factor α and interleukin-1β in subcutaneously implanted chamber by lipopolysaccharide 1997 ·Journal of Endotoxin Research ·Lior Shapira, Aubrey Soskolne, Amal Halabi, V. Barak, Adam Stabholz	3
10	IDENTIFICATION OF INTER-LEUKIN-2 IN HUMAN PERIPHERAL BLOOD EOSINOPHILS 1996 ·Shlomit Levi, J Barkans, T. M. Newman, (unknown), M Wakelin, Rosanne Stein, V. Barak, A. B. Kay, Redwan Moqbel	2
11	Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. 1996 ·Heart ·David Hasdai, Mickey Scheinowitz, Eyal Leibovitz, (unknown), M. Eldar, V. Barak	75
12	Imbalance of immune responses in patients with chronic and widespread fungal skin infection 1995 ·Clinical and Experimental Dermatology ·Vera Leibovici, (unknown), (unknown), Maxwell P. Westerman, Meir Shalit, V. Barak, Shoshana Frankenburg	21
13	1259 CYFRA 21-1 and TPS—new markers in lung cancer 1995 ·European Journal of Cancer ·Benjamin Nisman, Joel Lafair, Tamar Peretz, (unknown), V. Barak	6
14	High concentration of soluble interleukin-2 receptors in ejaculate with low sperm motility 1994 ·Human Reproduction ·Shlomo Shimonovitz, V. Barak, (unknown), P Ever-Hadani, (unknown), M. Ron	20
15	In vivo anti-inflammatory effects of the M20 IL-1 Inhibitor: II. Effects on serum reactants 1993 ·Biotherapy ·V. Barak, Raphael Gorodetsky, (unknown), David Peritt, (unknown), (unknown), Abraham J. Treves	5
16	The M20 IL-1 inhibitor 1992 ·Journal of Immunological Methods ·David Peritt, I. Flechner, (unknown), (unknown), (unknown), Abraham J. Treves, V. Barak	11
17	The M20 IL-1 inhibitor 1992 ·Journal of Immunological Methods ·David Peritt, I. Flechner, (unknown), (unknown), (unknown), Abraham J. Treves, V. Barak	9
18	Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with decarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response 1992 ·Immunology Letters ·Rut Isacson, Eli Kedar, V. Barak, Zulma Gazit, (unknown), (unknown), Hannah Ben‐Bassat, S Biran, Michael Schlesinger, C.R. Franks, (unknown), Peter Palmer, Eitan Shiloni	15
19	Recombinant human interleukin-1 suppresses lipoprotein lipase activity, but not expression of lipoprotein lipase mRNA in mesenchymal rat heart cell cultures 1991 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·G. Friedman, V. Barak, Tova Chajek‐Shaul, J Etienne, Abraham J. Treves, Oliver Stein, Y. Stein	11
20	Solitary nonparasitic cyst of the liver: a rare cause of abdominal distension. 1989 ·PubMed ·(unknown), V. Barak, Scott Fields, R.A. Bloom, E Okon, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact